Original language | English |
---|---|
Pages (from-to) | 555 |
Number of pages | 1 |
Journal | JOURNAL OF CLINICAL ONCOLOGY |
Volume | 41 |
DOIs | |
Publication status | Published - 2023 |
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC)
A Vogel, O Waidmann, T Muller, GM Siegler (Co-author), TO Goetze, EN De Toni, MA Gonzalez-Carmona, G Hausner, M Geissler, LF von Weikersthal, AMR Kestler, F Finkelmeier, M Kleiss, JU Marquardt, A Teufel, J Klagges, R Eickhoff, SE Al-Batran, AL Saborowski
Research output: Contribution to journal › Original Article › peer-review
4
Citations
(Web of Science)